We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Bioquell | LSE:BQE | London | Ordinary Share | GB0004992003 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 597.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From May 2019 to May 2024
TIDMBQE
RNS Number : 5395I
Bioquell PLC
26 March 2015
26 March, 2015
Bioquell PLC
Grant of options to Executive Directors
Bioquell PLC ("Bioquell") (LSE: BQE) announces that Nick Adams, Group Chief Executive of Bioquell, and Michael Roller, Group Finance Director, have been awarded options in accordance with the rules of the Bioquell Executive Share Option Schemes ("Options") over Bioquell ordinary shares with an exercise price of 120.5p.
Mr Adams has been awarded 254,000 Options. Mr Roller has been awarded 159,000 Options.
In order for the Options to vest Bioquell has to report earnings per share growth of RPI plus 7.5% compounded over three years.
- Ends -
Enquiries
Georgina Pope
Company Secretary
Bioquell PLC
01264 835 900
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSPGUAAWUPAUBQ
1 Year Bioquell Chart |
1 Month Bioquell Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
